F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Warm Fund

Odyssee Venture

odysseeventure.com · Paris, France

“A growth accelerator for ambitious French companies built on a frank, direct and rapid entrepreneur-investor relationship, backing founders through start-up to pre-IPO growth phases with resilience and collective intelligence.”

$1M – $10M
Check Size
$660M
AUM
01Investment Thesis

A growth accelerator for ambitious French companies built on a frank, direct and rapid entrepreneur-investor relationship, backing founders through start-up to pre-IPO growth phases with resilience and collective intelligence.

Exclusion Criteria

Not a seed-stage or non-French-market investor; focuses on growth-stage French SMEs rather than early ideation-stage companies.

02Investment Team
MB
Mathieu Boillet
Co-founder
SS
Sébastien Sassolas
Co-founder
JA
Julien Andrieux
Partner
GB
Gabrielle Boillet
Investment Officer
FV
Florent Violette
Directeur de participations
03F4 Research Brief

Odyssée Venture Research

Investment Thesis

Odyssée Venture describes itself as a growth accelerator for ambitious French companies, built on what it calls a "frank, direct and rapid" relationship between entrepreneurs and investors. Founded in November 1999 by Mathieu Boillet and Sébastien Sassolas, it was one of the first independent private equity management companies approved by the AMF (the French financial markets regulator), and has since become one of the longest-running dedicated growth investors in the French lower mid-market. The firm's thesis rests on four pillars: realizing founders' ambitions to build market-leading companies, helping portfolio companies overcome the inevitable challenges of a growth journey, solving complex problems through collective intelligence and engaged governance, and generating positive impact through job creation and innovation across digitalization, automation, energy transition, healthcare, and sustainable consumption.

Stage Focus

Odyssée invests across the growth spectrum, from start-up through pre-IPO. Its own language is "de la start-up à la pré-IPO, nous accompagnons tous ceux qui cherchent un associé expérimenté dans les phases de croissance forte de leur entreprise" — supporting companies through product launches, commercial acceleration, internationalization, and M&A build-ups.

Check Size

The firm's stated range is €1M–€10M per investment, typically alongside management teams in growth-stage French companies. Recent disclosed rounds include €14M (Meelo, with the Fonds Stratégique des Transitions), €11M (BrightHeart Series A), €38M (Veesion, syndicated), €8M (THX Pharma), and €4.5M (Veragrow) — consistent with Odyssée writing meaningful but not sole checks in larger syndicated rounds at the upper end of its range.

Lead Tendency

Odyssée emphasizes direct, fund-manager-led decision-making without a heavy investment committee process, and typically takes board seats with regular (roughly six-week) governance cadences. Public deal writeups do not consistently disclose lead/co-lead status, so this is recorded as unknown pending clearer confirmation.

Recent Activity

Odyssée manages 16 funds with approximately €660M in AUM and has completed nearly 200 investments in French SMEs since inception, with roughly 125 currently active in its portfolio. Recent activity (last 12 months) includes the Meelo strategic investment (Feb 2026), the BrightHeart Series A (Jan 2026), a post-IPO round in Afyren (Feb 2026), and continued portfolio realizations including the TeamSystem/ClicData exit (Jul 2025), the Syxperiane employee-led LBO exit (Jun 2025), and the Visma/Evoliz exit (Feb 2025). The firm plans to launch a new FCPI-JEI and a new FCPR fund in fall 2026 to continue backing French growth SMEs.

Portfolio Highlights

Odyssée's ~125-company active portfolio spans enterprise software (Esker, Sidetrade, Kameleoon, Flatchr, PeopleSpheres, Interstis), healthcare and medtech (Diabeloop, Cellectis, VitaDx, THX Pharma, AbbeLight, BrightHeart, NFL Biosciences), advanced materials and hardware (Soitec, ESI Group), aerospace (Elixir Aircraft), security/AI (Veesion, CircleSafe), edtech (GymGlish), consumer and retail (Love and Green, Jimmy Fairly, Ecomiam), and climate/energy (Afyren, Opera Energie). The firm has realized well over 100 exits historically, including notable names such as Streamwide, Kalray, ClicData (to TeamSystem), and Evoliz (to Visma).

Team

Publicly identified team members include:

  • Mathieu Boillet — Co-founder (1999)
  • Sébastien Sassolas — Co-founder (1999)
  • Julien Andrieux — Partner
  • Gabrielle Boillet — Investment Officer
  • Florent Violette — Directeur de participations (Portfolio Director)

The firm's website does not publish a dedicated team page with bios; the above names surface through portfolio-company testimonials and third-party firm databases (RocketReach, LinkedIn).

Decision Process

Odyssée describes a pragmatic, fund-manager-driven decision process rather than a formal investment committee gate, with an emphasis on speed and directness in entrepreneur relationships. Governance post-investment is structured around regular strategic committee meetings roughly every six weeks, with formal shareholder agreements defining rights and responsibilities.

Founder Preferences

Odyssée looks for "ambitious and enthusiastic entrepreneurs who want to make their company a market leader" and places heavy weight on resilience — "no business project is smooth sailing" — alongside management teams with complementary skills and a genuine desire to build substantial, durable enterprises.

Geographic Focus

Odyssée is exclusively focused on French growth companies, headquartered at 26 rue de Berri, 75008 Paris. It does not disclose meaningful investment activity outside France.

04Selected Portfolio
Biotech & Life Sciences
Cellectis·Afyren·THX Pharma·Veragrow·NFL Biosciences·AbbeLight·Terratis
Consumer Apps & Social
Engo
EdTech
GymGlish·SeriousFactory
Enterprise Software
Esker·Sidetrade·Kameleoon·ESI Group·Flatchr·TeamStarter·Munic·ClicData·Evoliz·Meelo·Interstis·Syxperiane
Food & Beverage
Ecomiam
Healthcare & Digital Health
Diabeloop·VitaDx·BrightHeart·SteriFrance·Datexim·Parsys
HR Tech & Future of Work
PeopleSpheres
Manufacturing & Industrial
Elixir Aircraft·CircleSafe·LPE
Robotics & Automation
Arcure
Security & Cybersecurity
Veesion
Semiconductors & Hardware
Soitec
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (6) →
Meelo secured a €14M strategic investment, welcoming the Fonds Stratégique des Transitions to its cap table.
INVESTMENT·odysseeventure.com
FEB 24, 2026
BrightHeart, a prenatal ultrasound AI medtech platform, raised an €11M Series A.
INVESTMENT·odysseeventure.com
JAN 8, 2026
Portfolio company ClicData was acquired by TeamSystem after Odyssée backed it since 2021.
EXIT·odysseeventure.com
JUL 7, 2025
Exited Syxperiane via an employee-participated LBO after entering the company in 2018.
EXIT·odysseeventure.com
JUN 19, 2025
AI retail-theft-detection company Veesion raised €38M to expand internationally.
INVESTMENT·odysseeventure.com
MAY 21, 2025
06Frequent co-investors
SP
Sofinnova Partners
Both backed 2 of the same companies
Afyren, BrightHeart
SI
Supernova Invest
Both backed 2 of the same companies
Afyren, Soitec
Find the investors for your round→
07Similar Firms
GC
GO CAPITAL
$200K – $5M · Pre-Seed · Seed
→
DC
Divergent Capital
$250K – $1M · Pre-Seed · Seed
→
B
b2venture
$250K – $5M · Pre-Seed · Seed
→
I
Innovestor
$250K – $3M · Pre-Seed · Seed
→
HV
Horizons Ventures
$1M – $25M · Pre-Seed · Seed
→
Quick Reference
Check Size
$1M – $10M
Stages
Series A · Series B · Growth
AUM
$660M
Decision
Partnership
Involvement
Board Seat
Location
Paris, France
Sector Focus
Aerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareEdTechClimate & SustainabilityEnterprise SoftwareHR Tech & Future Of WorkFood & BeverageSecurity & CybersecurityHealthcare & Digital Health
Models
Enterprise SoftwareSaaSHR TechMedTechConsumer Goods
Technology
AI/MLHardwareBiotech
See all Aerospace & Defense investors →See all Biotech & Life Sciences investors →See all Semiconductors & Hardware investors →
Visit odysseeventure.com ↗

See how Odyssee Venture matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Aerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareEdTechClimate & SustainabilityEnterprise SoftwareHR Tech & Future Of WorkFood & BeverageSecurity & CybersecurityHealthcare & Digital Health

See how Odyssee Venture matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched August 29, 2026F4 Research Engine